大腸菌株市場：菌株の種類別、用途別、病原性別、エンドユーザー別、地域別

大腸菌株市場の市場規模は、2025年に22億6,000万米ドルと推定され、2032年には36億1,000万米ドルに達すると予測され、2025年から2032年までのCAGRは6.9%で推移すると予測されています。

一般にE. coliとして知られる大腸菌は、その多様な性質と研究における広範な使用により、科学的に大きな関心を集めている細菌株です。この細菌は腸内細菌科に属し、通常、ヒトや動物の消化管に存在します。大腸菌はしばしば食中毒や感染症に関連していますが、すべての菌株が有害であるわけではないことに注意することが重要です。実際、多くの菌株は有益であり、消化器系で重要な役割を果たし、食物の分解と栄養素の吸収を助けています。しかし、病原性を持つ大腸菌も存在し、軽度の胃腸障害から尿路感染症、肺炎、さらには生命を脅かす溶血性尿毒症症候群のような重篤な症状まで、様々な病気を引き起こす可能性があります。大腸菌がこのように幅広い疾患を引き起こす能力を持つことから、公衆衛生上の重要な懸念事項となっています。大腸菌の多様な性質と、健康と疾病の両方におけるその役割から、大腸菌は科学研究にとって極めて重要なモデル生物となっています。大腸菌は遺伝学、生化学、バイオテクノロジーの分野で幅広く研究されており、これらの分野の理解に大きく貢献しています。研究者は大腸菌を用いて、細菌の遺伝学的研究、代謝経路の調査、新しいバイオテクノロジー応用の開発を行っています。このような広範な研究は、大腸菌そのものに関する知識を深めるだけでなく、より広範な生物学的プロセスに関する貴重な洞察をもたらしています。

市場力学：

バイオテクノロジー研究、組換えタンパク質生産、医薬品開発が、予測期間における世界の大腸菌株市場の成長を牽引すると予想されます。さらに、工業プロセスも、予測期間における世界の大腸菌株市場の成長を後押しすると予想されます。バイオ医薬品生産、合成生物学、個別化医療、バイオレメディエーションは、予測期間中、世界の大腸菌市場に成長機会をもたらすと期待されています。

しかし、安全性やバイオセキュリティへの懸念、規制上のハードル、他の微生物との競合、汚染や交差汚染のリスクが、予測期間中の大腸菌株市場の成長を妨げると予想されます。

当レポートの主な特徴

• 当レポートは、世界の大腸菌株市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模・CAGRを掲載しています。
• また、各セグメントの潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場の促進要因・抑制要因や機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 世界の大腸菌株市場における主要企業プロファイルを、企業概要、製品ポートフォリオ、主要なハイライト、財務実績、戦略などの以下のパラメータに基づいて掲載しています。
• 当レポートの洞察を用いて、マーケティング担当者や企業の経営陣が、将来の製品発売・提携・市場拡大・マーケティング戦術に関する、十分な情報に基づいた意思決定を下すことができます。
• 「大腸菌株市場」レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
• 利害関係者は、世界の大腸菌株市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 分析目的と前提条件

• 分析目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map (COM)

第3章 市場力学・規制・動向の分析

• 市場力学
• 影響分析
  • バイオテクノロジー調査は予測期間中に市場の成長を牽引すると予想されている
• 抑制要因
  • 安全性とバイオセキュリティに関する懸念は、予測期間中の市場の成長を妨げると予想されます。
• 機会
  • 精密医療アプリケーション向けにカスタムメイドの大腸菌株を提供する個別化医療は、市場機会をもたらすことが期待されています。
• 主なハイライト
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• ポーターのファイブフォース分析
• 企業合併・買収 (M&A) ・提携分析

第4章 大腸菌株市場：新型コロナウイルス感染症 (COVID-19) パンデミックの影響

• COVID-19の疫学
• 供給側と需要側の分析
• 経済への影響

第5章 大腸菌株市場：菌株の種類別（2020～2032年）

• 共生菌株
• 下痢性菌株
• 腸管外病原性株
• 尿路病原性株
• 新生児髄膜炎菌株
• その他

第6章 大腸菌株市場：用途別（2020～2032年）

• 診断
• 研究
• 治療薬
• 組み換えタンパク質の生産
• 品質管理生物
• その他

第7章 大腸菌株市場：病原性別（2020～2032年）

• 病原性大腸菌
• 非病原性大腸菌

第8章 大腸菌株市場：エンドユーザー別（2020～2032年）

• 研究機関
• 診断検査室
• 製薬・バイオテクノロジー企業
• CRO（医薬品開発業務受託機関）
• その他

第9章 大腸菌株市場：地域別（2020～2032年）

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東
• アフリカ

第10章 競合情勢

• 企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Novozymes A/S
  • QIAGEN NV
  • Promega Corporation
  • Agilent Technologies, Inc.
  • New England Biolabs, Inc.
  • Takara Bio Inc.
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation
  • Sanofi
  • Xiamen Innovax Biotech Co., Ltd

第11章 セクション

• 参考文献
• 調査手法
• 出版社について

Escherichia Coli Strain Market is estimated to be valued at USD 2.26 Bn in 2025 and is expected to reach USD 3.61 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032.

Escherichia Coli, commonly known as E. coli, is a strain of bacteria that has garnered significant scientific interest due to its diverse nature and extensive use in research. This bacterium belongs to the Enterobacteriaceae family and is typically found in the gastrointestinal tract of humans and animals. While E. coli is often associated with foodborne illnesses and infections, it's important to note that not all strains are harmful. In fact, many strains are beneficial and play a crucial role in the digestive system, aiding in the breakdown of food and absorption of nutrients. These beneficial strains also help in maintaining a healthy gut flora, which is essential for overall health.However, there are certain strains of E. coli that are pathogenic and can cause a range of illnesses, from minor gastrointestinal upset to severe conditions like urinary tract infections, pneumonia, and even life-threatening hemolytic uremic syndrome. The ability of E. coli to cause such a wide spectrum of diseases makes it a significant public health concern. E. coli's versatile nature and its role in both health and disease have made it a crucial model organism for scientific research. It is extensively studied in the fields of genetics, biochemistry, and biotechnology, contributing significantly to our understanding of these areas. Researchers use E. coli to study bacterial genetics, investigate metabolic pathways, and develop new biotechnological applications. This extensive research has not only enhanced our knowledge of E. coli itself but also provided valuable insights into broader biological processes.

Market Dynamics:

Biotechnology research, recombinant protein production and pharmaceutical development are anticipated to drive the growth of the global escherichia coli strain market over the forecast period. Moreover, industrial processes are also expected to boost the growth of the global escherichia coli strain market over the forecast period. Biopharmaceutical production, synthetic biology, personalized medicine, and bioremediation are expected to create growth opportunities for the global Escherichia Coli Strain market during the forecast period.

However, safety and biosecurity concerns, regulatory hurdles, competition from other microorganisms and contamination and cross-contamination risks are expected to hamper growth of the escherichia coli strain market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global escherichia coli strain market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global escherichia coli strain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Novozymes A/S, QIAGEN N.V., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, Sanofi, and Xiamen Innovax Biotech Co., Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global escherichia coli strain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global escherichia coli strain market

Detailed Segmentation:

• Escherichia Coli Strain Market, By Strain Type:
  • Commensal strains
  • Diarrheal strains
  • Extraintestinal pathogenic strains
  • Uropathogenic strains
  • Neonatal meningitis strains
  • Others
• Escherichia Coli Strain Market, By Application:
  • Diagnostics
  • Research
  • Therapeutics
  • Production of recombinant proteins
  • Quality control organisms
  • Others
• Escherichia Coli Strain Market, By Pathogenicity:
  • Pathogenic E. coli
  • Non-pathogenic E. coli
• Escherichia Coli Strain Market, By End User:
  • Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Others
• Escherichia Coli Strain Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Novozymes A/S
  • QIAGEN N.V.
  • Promega Corporation
  • Agilent Technologies, Inc.
  • New England Biolabs, Inc.
  • Takara Bio Inc.
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation
  • Sanofi
  • Xiamen Innovax Biotech Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Strain Type
  • Market Snippet, By Application
  • Market Snippet, By Pathogenicity
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Biotechnology research is expected to drive the market growth over forecast period
  • Restraints
• Safety and biosecurity concerns is expected to hinder the market growth over forecast period
  • Opportunities
• Personalized medicine to provide custom-made E. coli strains for precision medicine applications is expected to provide market opportunity
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Escherichia Coli Strain Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Escherichia Coli Strain Market, By Strain Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Commensal strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diarrheal strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Extraintestinal pathogenic strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Uropathogenic strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Neonatal meningitis strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Escherichia Coli Strain Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Production of recombinant proteins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Quality control organisms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Escherichia Coli Strain Market, By Pathogenicity, 20218-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%) Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pathogenic E. coli
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Non-pathogenic E. coli
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Escherichia Coli Strain Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Escherichia Coli Strain Market, By Geography, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Thermo Fisher Scientific Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Merck KGaA
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Novozymes A/S
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • QIAGEN N.V.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Promega Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Agilent Technologies, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • New England Biolabs, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Takara Bio Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Bio-Rad Laboratories, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • GenScript Biotech Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Sanofi
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Xiamen Innovax Biotech Co., Ltd
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

11. Section

• References
• Research Methodology
• About us